文献速递神经肿瘤功能神经外科

内镜下经鼻骨性减压与选择性肿瘤切除治疗海绵窦及Meckel腔脑膜瘤的策略

Strategy and Technique of Endonasal Endoscopic Bony Decompression and Selective Tumor Removal in Symptomatic Skull Base Meningiomas of the Cavernous Sinus and Meckel's Cave.
PubMed 文献 · World Neurosurg · 2019-06-19

既往未治疗组肿瘤控制率100%,曾手术放疗组仅33%(P<0.001),颅神经病变改善率分别为57%和33%。

要点

  • 内镜经鼻骨性减压+选择性切除+SRT对多数初治鞍旁脑膜瘤是合理选择
  • 初治组肿瘤控制率100%,既往治疗组仅33%,差异显著
  • 主要并发症为永久性展神经麻痹和需再手术的脑脊液漏

核心结论

  • 内镜经鼻骨性减压和选择性肿瘤切除后辅以SRT,对多数既往未治疗的鞍旁脑膜瘤是合理治疗选择。
  • 对既往已行减容和放疗的患者,肿瘤控制率低,需要新的靶向治疗策略。

研究设计与样本

  • 患者年龄43-81岁,65%为女性,90%为WHO I级,中位随访57个月;14例无既往减容和放疗,6例有既往减容和放疗。

主要发现

  • 最常见肿瘤位置为海绵窦(95%)、Meckel腔(95%)、蝶鞍(75%)、岩斜区(60%)和视神经管/眶(30%)。
  • 3例大体积脑膜瘤接受了分期经颅和经鼻减容。
  • 14例无既往减容和放疗的患者中,11例术后接受SRT,其中3例(27%)肿瘤缩小。
  • 末次随访时,14例初治患者和6例既往手术放疗患者的肿瘤控制率分别为100%和33%(P < 0.001)。
  • 颅神经病变改善率在初治组和既往治疗组分别为57%和33%。

关键数值与推荐

  • 初治组肿瘤控制率100%,既往减容和放疗组33%(P < 0.001)。
  • 初治组颅神经病变改善率57%,既往治疗组33%。
  • 术后接受SRT的11例中3例(27%)肿瘤缩小。

临床怎么用

  • 对既往未治疗的鞍旁脑膜瘤,可考虑内镜经鼻骨性减压联合选择性肿瘤切除,术后辅以SRT。
  • 对既往已行减容和放疗的患者,需谨慎评估,考虑新的治疗策略。

局限性

  • 单中心经验,随访时间中位57个月,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Parasellar meningiomas involving the cavernous sinus and Meckel's cave pose a management challenge because of invasion around neurovascular structures and the pituitary gland. The management options range from aggressive resection to focused radiotherapy alone. We present a strategy for these tumors that includes endonasal bony decompression, partial tumor removal, and stereotactic radiotherapy (SRT) in select cases. METHODS: The tumor location, previous treatments, cranial neuropathies, pituitary dysfunction, tumor control rates, use of stereotactic radiosurgery, SRT, and complications were retrospectively evaluated. RESULTS: Twenty patients (age range, 43-81 years; 65% women; 90% with World Health Organization grade I; median follow-up, 57 months; 14 without previous debulking and RT; 6 with previous debulking and RT) underwent endonasal bony decompression and partial tumor removal. The most common tumor locations were cavernous sinus (95%), Meckel's cave (95%), sella (75%), petroclival (60%), and optic canal/orbit (30%). Three patients with large meningiomas underwent staged transcranial and endonasal debulking. Of the 14 patients without previous debulking and RT, 11 had undergone postoperative SRT, with tumor shrinkage in 3 (27%). At the last follow-up examination, for these 14 patients and the 6 patients who had undergone previous surgery and RT, tumor control was 100% and 33% (P < 0.001) and the cranial neuropathies had improved in 57% and 33%, respectively. Major complications occurred in 2 patients: a permanent sixth cranial nerve palsy and cerebrospinal fluid leakage requiring reoperation. CONCLUSIONS: Endonasal bony decompression and selective tumor removal, followed by SRT, appears to be a reasonable treatment option for most previously untreated parasellar meningiomas. For patients who have undergone previous debulking and RT, new targeted treatment strategies are needed.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Sivakumar W, Barkhoudarian G, Lobo BM, et al. Strategy and Technique of Endonasal Endoscopic Bony Decompression and Selective Tumor Removal in Symptomatic Skull Base Meningiomas of the Cavernous Sinus and Meckel's Cave. World Neurosurg. 2019. PMID: 31226453. doi:10.1016/j.wneu.2019.06.073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。